Orange Book product · Generic (ANDA)
ZIDOVUDINE
ZIDOVUDINE
At a glance
Sep 19, 2005
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 19, 2005
21 yr 1 mo ago
Today
Pharmaceutical detail
Active ingredient
ZIDOVUDINE
Strength
300MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 077267
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ZIDOVUDINE
- 2011ZIDOVUDINEBrand (NDA)
NDA 200732 · PHARMOBEDIENT
- 2009ZIDOVUDINEBrand (NDA)
NDA 022294 · AUROBINDO PHARMA
- 1995RETROVIRBrand (NDA)
NDA 020518 · VIIV HLTHCARE
- 1990RETROVIRBrand (NDA)
NDA 019951 · VIIV HLTHCARE
- 1989RETROVIRBrand (NDA)
NDA 019910 · VIIV HLTHCARE
- 1987RETROVIRBrand (NDA)
NDA 019655 · VIIV HLTHCARE
- 2013ZIDOVUDINEGeneric (ANDA)
ANDA 204538 · LIAONING CHENGDA
- 2011ZIDOVUDINEGeneric (ANDA)
ANDA 202058 · HEC PHARM
- 2010ZIDOVUDINEGeneric (ANDA)
ANDA 090561 · CIPLA
- 2010ZIDOVUDINEGeneric (ANDA)
ANDA 091457 · AM REGENT
- 2008ZIDOVUDINEGeneric (ANDA)
ANDA 077981 · CIPLA LTD
- 2008ZIDOVUDINEGeneric (ANDA)
ANDA 090092 · HETERO LABS LTD III
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
